The biological characterization of compounds 1 and 7 started with the evaluation of their ability to bind TSPO, and to induce, through TSPO activation, Δψm collapse in mitochondria isolated from GBM cells (Figure 3). The gene discussed is TSPO; the disease is glioblastoma.